The Archive · 5 posts
Advancing science for patient care! 🌟 AstraZeneca PLC (AZN) is on the forefront of medical innovation. Discover more on the LSE today! 💉
Showing 4 of 5 posts
AstraZeneca's $1.2bn CSPC deal secures once-monthly obesity injections and AI-driven peptide tech, expanding its weight management pipeline.
JoshuaJanuary 30, 2026
AstraZeneca slashes US drug prices by 80% in historic government deal, boosting manufacturing with a $50B investment for future growth.
JoshuaOctober 13, 2025
AstraZeneca reports stellar H1 growth with 11% revenue surge and pledges $50B US investment for Virginia manufacturing hub, powering future metabolic pipeline expansion. (148 characters)
JoshuaJuly 29, 2025
AstraZeneca's £800m EsoBiotec acquisition pioneers IV-administered cell therapies targeting cancer and autoimmune diseases via revolutionary ENaBL platform.
JoshuaMay 20, 2025
July 29, 2025